Exxon Mobil, ProShares UltraPro Short QQQ, Direxion Daily TSLA Bull 2X Shares, Chevron, Ford Motor, AbbVie, and Pfizer are the seven Dividend stocks to watch today, according to MarketBeat's stock screener tool. Dividend stocks are shares of companies that regularly distribute a portion of their profits to shareholders, typically on a quarterly basis. By owning these stocks, investors receive steady income payments in addition to any capital appreciation. Companies that pay reliable dividends often signal solid cash flow and financial stability, making them attractive to income-focused investors. These companies had the highest dollar trading volume of any Dividend stocks within the last several days.
Exxon Mobil (XOM)
Exxon Mobil Corporation engages in the exploration and production of crude oil and natural gas in the United States and internationally. It operates through Upstream, Energy Products, Chemical Products, and Specialty Products segments. The Upstream segment explores for and produces crude oil and natural gas.
Exxon Mobil stock traded up $1.10 during mid-day trading on Friday, reaching $112.15. The company's stock had a trading volume of 11,223,580 shares, compared to its average volume of 15,759,096. The company has a market capitalization of $483.33 billion, a price-to-earnings ratio of 14.87, a price-to-earnings-growth ratio of 2.16 and a beta of 0.50. Exxon Mobil has a 12 month low of $97.80 and a 12 month high of $126.34. The business's 50 day simple moving average is $107.32 and its 200 day simple moving average is $108.51. The company has a debt-to-equity ratio of 0.12, a quick ratio of 0.90 and a current ratio of 1.24.
Read Our Latest Research Report on XOM
ProShares UltraPro Short QQQ (SQQQ)
ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.
ProShares UltraPro Short QQQ stock traded down $0.52 during mid-day trading on Friday, reaching $19.15. The company's stock had a trading volume of 62,098,634 shares, compared to its average volume of 64,246,478. ProShares UltraPro Short QQQ has a 12 month low of $19.02 and a 12 month high of $57.95. The business's 50 day simple moving average is $23.96 and its 200 day simple moving average is $29.94.
Read Our Latest Research Report on SQQQ
Direxion Daily TSLA Bull 2X Shares (TSLL)
Direxion Daily TSLA Bull 2X Shares stock traded down $0.18 during mid-day trading on Friday, reaching $11.41. The company's stock had a trading volume of 91,041,950 shares, compared to its average volume of 116,097,076. The company has a market capitalization of $6.26 billion, a price-to-earnings ratio of 88.55 and a beta of -5.14. Direxion Daily TSLA Bull 2X Shares has a 12 month low of $6.29 and a 12 month high of $41.50. The business's 50 day simple moving average is $12.73 and its 200 day simple moving average is $16.22.
Read Our Latest Research Report on TSLL
Chevron (CVX)
Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant.
Chevron stock traded up $0.25 during mid-day trading on Friday, reaching $148.23. The company's stock had a trading volume of 5,173,309 shares, compared to its average volume of 8,273,025. The company has a market capitalization of $258.86 billion, a price-to-earnings ratio of 16.94, a price-to-earnings-growth ratio of 2.51 and a beta of 0.83. Chevron has a 12 month low of $132.04 and a 12 month high of $168.96. The business's 50 day simple moving average is $141.16 and its 200 day simple moving average is $148.07. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.82 and a current ratio of 1.08.
Read Our Latest Research Report on CVX
Ford Motor (F)
Ford Motor Company develops, delivers, and services a range of Ford trucks, commercial cars and vans, sport utility vehicles, and Lincoln luxury vehicles worldwide. It operates through Ford Blue, Ford Model e, and Ford Pro; Ford Next; and Ford Credit segments. The company sells Ford and Lincoln vehicles, service parts, and accessories through distributors and dealers, as well as through dealerships to commercial fleet customers, daily rental car companies, and governments.
F stock traded up $0.03 during trading hours on Friday, reaching $11.80. The stock had a trading volume of 60,311,463 shares, compared to its average volume of 82,739,639. The stock has a market capitalization of $46.90 billion, a PE ratio of 9.44, a price-to-earnings-growth ratio of 1.01 and a beta of 1.49. The company has a debt-to-equity ratio of 2.26, a current ratio of 1.13 and a quick ratio of 0.97. The stock has a 50-day simple moving average of $10.53 and a 200 day simple moving average of $10.01. Ford Motor has a fifty-two week low of $8.44 and a fifty-two week high of $14.85.
Read Our Latest Research Report on F
AbbVie (ABBV)
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.
ABBV stock traded down $1.25 during trading hours on Friday, reaching $189.50. The stock had a trading volume of 3,706,217 shares, compared to its average volume of 6,248,905. The stock has a market capitalization of $334.73 billion, a PE ratio of 80.64, a price-to-earnings-growth ratio of 1.26 and a beta of 0.48. The company has a debt-to-equity ratio of 44.14, a current ratio of 0.76 and a quick ratio of 0.64. The stock has a 50-day simple moving average of $187.37 and a 200 day simple moving average of $188.46. AbbVie has a fifty-two week low of $163.63 and a fifty-two week high of $218.66.
Read Our Latest Research Report on ABBV
Pfizer (PFE)
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.
PFE stock traded up $0.13 during trading hours on Friday, reaching $25.45. The stock had a trading volume of 27,104,580 shares, compared to its average volume of 41,625,077. The stock has a market capitalization of $144.66 billion, a PE ratio of 18.44, a price-to-earnings-growth ratio of 0.92 and a beta of 0.58. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.26 and a quick ratio of 0.96. The stock has a 50-day simple moving average of $23.72 and a 200 day simple moving average of $24.83. Pfizer has a fifty-two week low of $20.92 and a fifty-two week high of $31.54.
Read Our Latest Research Report on PFE
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Exxon Mobil, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exxon Mobil wasn't on the list.
While Exxon Mobil currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
